248 related articles for article (PubMed ID: 11086180)
21. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells.
Moriai R; Asanuma K; Kobayashi D; Yajima T; Yagihashi A; Yamada M; Watanabe N
Anticancer Res; 2001; 21(1B):595-600. PubMed ID: 11299811
[TBL] [Abstract][Full Text] [Related]
22. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells.
Yamada K; Yajima T; Yagihashi A; Kobayashi D; Koyanagi Y; Asanuma K; Yamada M; Moriai R; Kameshima H; Watanabe N
Jpn J Cancer Res; 2000 Dec; 91(12):1278-84. PubMed ID: 11123427
[TBL] [Abstract][Full Text] [Related]
23. [Expression of survivin and its location in bone marrow cells of childhood acute leukemia: relationship to therapeutic efficacy].
Hou Y; Hu Q; Liu AG; Zhang LQ; Liu SY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):101-4. PubMed ID: 16613699
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases.
Zhao ZG; Liang Y; Li K; Li WM; Li QB; Chen ZC; Zou P
Stem Cells Dev; 2007 Aug; 16(4):637-48. PubMed ID: 17784837
[TBL] [Abstract][Full Text] [Related]
25. Absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia.
Köhler T; Leiblein S; Borchert S; Eller J; Rost AK; Lassner D; Krahl R; Helbig W; Wagner O; Remke H
Adv Exp Med Biol; 1999; 457():177-85. PubMed ID: 10500792
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of survivin expression in subtypes of lymphoma].
Gu X; Lin HL
Ai Zheng; 2004 Jun; 23(6):655-61. PubMed ID: 15191665
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells.
Anuchapreeda S; Thanarattanakorn P; Sittipreechacharn S; Tima S; Chanarat P; Limtrakul P
Arch Pharm Res; 2006 Oct; 29(10):866-73. PubMed ID: 17121181
[TBL] [Abstract][Full Text] [Related]
28. Expression and functional significance of osteocalcin splicing in disease progression of hematological malignancies.
Wihlidal P; Varga F; Pfeilstöcker M; Karlic H
Leuk Res; 2006 Oct; 30(10):1241-8. PubMed ID: 16387359
[TBL] [Abstract][Full Text] [Related]
29. Argininosuccinate synthetase gene expression in leukemias: potential diagnostic marker for blastic crisis of chronic myelocytic leukemia.
Ohno T; Kimura Y; Sakurada K; Sugimura K; Fujiyoshi T; Saheki T; Sonoda S; Azuma I
Leuk Res; 1992; 16(5):475-83. PubMed ID: 1625473
[TBL] [Abstract][Full Text] [Related]
30. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
Burger H; Nooter K; Zaman GJ; Sonneveld P; van Wingerden KE; Oostrum RG; Stoter G
Leukemia; 1994 Jun; 8(6):990-7. PubMed ID: 7911548
[TBL] [Abstract][Full Text] [Related]
31. Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.
Stock W; Yu D; Karrison T; Sher D; Stone RM; Larson RA; Bloomfield CD
Int J Oncol; 2006 May; 28(5):1099-103. PubMed ID: 16596225
[TBL] [Abstract][Full Text] [Related]
32. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
33. [Expression of survivin gene in NB4 cell line and cells of acute promyelocytic leukemia and its anti-apoptosis and clinical significance].
Xue J; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):332-6. PubMed ID: 16638209
[TBL] [Abstract][Full Text] [Related]
34. [Advance of research on survivin in hematological malignancies--review].
Xiong HX; Chen BA; Ding JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):866-9. PubMed ID: 15631681
[TBL] [Abstract][Full Text] [Related]
35. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
36. [The role of the inhibitor of apoptosis protein (IAP) family in hematological malignancies].
Grzybowska-Izydorczyk O; Smolewski P
Postepy Hig Med Dosw (Online); 2008 Feb; 62():55-63. PubMed ID: 18283236
[TBL] [Abstract][Full Text] [Related]
37. Distinguishing between proliferating nodal lymphoid blasts in chronic myelogenous leukemia and non-Hodgkin lymphoma: report of three cases and detection of a bcr/abl fusion signal by single-cell analysis.
Yashima-Abo A; Satoh T; Abo T; Aoki Y; Kowata S; Ito S; Ishida Y; Fujiwara H; Maesawa C; Masuda T
Pathol Int; 2005 May; 55(5):273-9. PubMed ID: 15871725
[TBL] [Abstract][Full Text] [Related]
38. Expression of the antiapoptosis gene survivin in human leukemia.
Mori A; Wada H; Nishimura Y; Okamoto T; Takemoto Y; Kakishita E
Int J Hematol; 2002 Feb; 75(2):161-5. PubMed ID: 11939262
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.
Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ
Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136
[TBL] [Abstract][Full Text] [Related]
40. Expression of IAP-family proteins in adult acute mixed lineage leukemia (AMLL).
Nakagawa Y; Hasegawa M; Kurata M; Yamamoto K; Abe S; Inoue M; Takemura T; Hirokawa K; Suzuki K; Kitagawa M
Am J Hematol; 2005 Mar; 78(3):173-80. PubMed ID: 15726601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
